What is HC Wainwright’s Forecast for CVE:HIV Q1 Earnings?

by · The Cerbat Gem

HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Equities researchers at HC Wainwright issued their Q1 2026 EPS estimates for HIVE Blockchain Technologies in a research note issued to investors on Thursday, November 14th. HC Wainwright analyst M. Colonnese forecasts that the company will post earnings per share of ($0.04) for the quarter. HC Wainwright currently has a “Strong-Buy” rating on the stock. HC Wainwright also issued estimates for HIVE Blockchain Technologies’ Q2 2026 earnings at $0.00 EPS, Q3 2026 earnings at $0.06 EPS and FY2026 earnings at $0.06 EPS.

HIV has been the subject of several other research reports. Cantor Fitzgerald raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Tuesday, October 29th. Northland Capmk upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Thursday, September 19th.

View Our Latest Stock Analysis on HIV

HIVE Blockchain Technologies Stock Performance

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.

Further Reading